Recombinant Xenopus tropicalis Protein FAM136A (fam136a) is a mitochondrial protein expressed in the Western clawed frog (Silurana tropicalis). It is produced via recombinant DNA technology, enabling controlled studies of its structure, function, and role in biological processes. FAM136A is conserved across species and has been implicated in human diseases such as familial Meniere’s disease, making it a critical target for biomedical research .
Purity:
Antibody Production: Used as an immunogen to generate antibodies targeting FAM136A .
Disease Modeling:
Protein-Protein Interaction Screens: Tags enable pull-down assays to identify binding partners .
Species-Specificity: Enables comparative studies in Xenopus tropicalis, a diploid model with high genomic synteny to humans .
CRISPR Compatibility: Facilitates functional knockout studies in F0-generation embryos .
Genetic Tools: High fecundity, rapid development, and CRISPR efficiency enable large-scale functional screens .
Evolutionary Conservation: Shares 79% of human disease-associated genes, validating translational relevance .
FAM136A (Family with Sequence Similarity 136, Member A) is a protein with relatively limited characterization in Xenopus tropicalis. Based on comparative studies with other species, FAM136A appears to encode a mitochondrial protein, though its specific function remains largely unknown . Immunohistochemical studies in rat inner ear tissue have demonstrated that FAM136A co-localizes with the mitochondrial marker COX IV in the basal part of hair cells in the crista ampullaris, suggesting potential roles in sensory epithelium function . The protein's conservation across vertebrates, including frogs, suggests it likely serves important cellular functions.
FAM136A shows significant conservation across amphibian species, particularly between Xenopus laevis and Xenopus tropicalis. The protein sequence exhibits high similarity between these closely related species, which supports the use of either model for studying FAM136A function . Both species express FAM136A and have been utilized in various genetic and biochemical studies exploring protein function in amphibians . When comparing amphibian FAM136A to mammalian orthologs, key functional domains appear to be preserved, suggesting evolutionary conservation of critical functional regions.
The structural characteristics of Xenopus tropicalis FAM136A remain partially characterized. Based on available data, FAM136A is expressed as multiple transcript isoforms that encode protein variants . The full-length protein appears to contain functional domains important for mitochondrial localization and function. Recombinant expression systems have successfully produced the protein with various tags (including His tags) that maintain structural integrity for experimental applications . Multiple isoforms have been detected through both mRNA analysis and immunoblotting, suggesting differential processing or alternative splicing may generate functional diversity in this protein family .
Yeast expression systems have proven particularly effective for recombinant production of Xenopus FAM136A proteins. The yeast expression system provides an economical and efficient eukaryotic platform for both secretion and intracellular expression of recombinant proteins . For Xenopus tropicalis FAM136A specifically, yeast expression systems consistently yield protein with greater than 90% purity suitable for applications such as ELISA . Mammalian cell expression systems (such as HEK-293 cells) offer an alternative approach that may produce protein with post-translational modifications more closely resembling the native state, though at higher cost and potentially lower yield than yeast-based systems .
The most effective purification approach for recombinant Xenopus tropicalis FAM136A involves affinity chromatography utilizing His-tag fusion proteins. This method typically yields protein preparations with purity exceeding 90% as determined by SDS-PAGE analysis . The purification workflow generally involves:
Expression of His-tagged FAM136A in yeast expression systems
Cell lysis under conditions that maintain protein solubility
Immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar matrices
Washing steps with increasing imidazole concentrations to remove non-specifically bound proteins
Elution of purified FAM136A with high imidazole buffer
Optional size exclusion chromatography for applications requiring exceptionally high purity
This approach consistently yields recombinant FAM136A suitable for applications including ELISA and other functional studies .
Verification of proper folding and activity for recombinant Xenopus tropicalis FAM136A requires multiple analytical approaches:
Structural integrity analysis:
Circular dichroism spectroscopy to assess secondary structure content
Size exclusion chromatography to confirm monomeric state vs. aggregation
Limited proteolysis to verify compact folding
Functional assays:
Activity verification:
While specific enzymatic activities remain undefined for FAM136A, mitochondrial import assays can verify proper targeting
Complementation assays in FAM136A-deficient systems can assess functional activity
Multiple transcript isoforms should be evaluated individually, as functional differences between isoforms have been observed in expression studies .
CRISPR/Cas9 gene editing represents a powerful approach for studying FAM136A function in Xenopus tropicalis. This methodology offers several key advantages for FAM136A functional studies:
Efficient gene knockout generation:
Xenopus tropicalis embryos readily accept microinjection of CRISPR/Cas9 components
Simple insertions and deletions (indels) can be generated with high efficiency, typically exceeding 90% when measured using TIDE analysis
Targeting can be designed to disrupt specific functional domains or create complete gene knockouts
Experimental design considerations:
Guide RNA design should target conserved exons present in all FAM136A transcript isoforms
Microinjection into synchronous embryos at early developmental stages ensures widespread genomic editing
F0 animals will exhibit mosaicism due to rapid cell divisions and low incubation temperature
For germline transmission studies, crossing F0 mosaic animals is necessary to establish stable lines
Analysis approaches:
While F0 CRISPR-edited Xenopus tropicalis will display mosaicism, the high penetrance of mutations often allows meaningful phenotypic analysis without establishing stable lines, particularly for initial functional screens .
Systematic protein interaction studies for FAM136A in Xenopus systems remain limited. Based on available data and localization studies, several potential interaction networks merit investigation:
Mitochondrial protein interactions:
Methodological approaches for interaction studies:
Proximity labeling techniques (BioID, APEX) using FAM136A as bait in Xenopus cell systems
Co-immunoprecipitation using tagged recombinant FAM136A protein
Yeast two-hybrid screening against Xenopus tropicalis cDNA libraries
Mass spectrometry analysis of purified mitochondrial complexes containing FAM136A
Isoform-specific interactions:
Researchers should design interaction studies accounting for mitochondrial localization, potentially using mitochondria-targeted split-reporter systems or organelle-specific protein complementation assays to minimize false positives from non-physiological compartment mixing.
Robust experimental design for FAM136A functional studies requires comprehensive controls addressing both technical and biological variables:
Genetic manipulation controls:
For CRISPR/Cas9 experiments, include non-targeting gRNA controls to assess injection effects
For morpholino studies, include standard control morpholinos and rescue experiments with wildtype FAM136A mRNA to verify specificity
For overexpression studies, include equivalent expression of unrelated proteins to control for general protein burden effects
Expression analysis controls:
For qPCR studies of FAM136A transcript levels, multiple reference genes validated for stability in the experimental context should be used
Western blot loading controls should include both housekeeping proteins and markers specific to mitochondrial content
Multiple antibodies targeting different epitopes should be used when possible to confirm specificity
Functional assay controls:
Include positive controls for mitochondrial function assays using established mitochondrial proteins
Perform parallel analyses in both Xenopus laevis and Xenopus tropicalis when possible to confirm conserved functions
Include genetic background controls, particularly when using inbred or transgenic Xenopus tropicalis strains
| Control Type | Purpose | Implementation |
|---|---|---|
| Negative controls | Establish baseline and non-specific effects | Non-targeting gRNAs, control morpholinos, vehicle treatments |
| Positive controls | Verify assay functionality | Known mitochondrial protein manipulations, established phenotypes |
| Rescue controls | Confirm specificity of observed effects | Wild-type FAM136A expression in knockout/knockdown systems |
| Specificity controls | Distinguish isoform-specific functions | Selective targeting or rescue with specific FAM136A isoforms |
Investigating the mitochondrial function of FAM136A in Xenopus tropicalis requires a multi-faceted experimental approach:
Subcellular localization studies:
Generate fluorescently-tagged FAM136A constructs for live imaging in Xenopus cells or embryos
Perform co-localization studies with established mitochondrial markers like COX IV
Use subcellular fractionation to biochemically confirm mitochondrial association
Identify mitochondrial targeting sequences and generate deletion constructs to verify import mechanisms
Functional impact assessment:
Measure mitochondrial respiration in FAM136A-depleted vs. control cells using respirometry
Assess mitochondrial membrane potential with fluorescent indicators following FAM136A manipulation
Examine mitochondrial morphology through electron microscopy and fluorescence imaging
Analyze mitochondrial protein import efficiency in FAM136A-deficient systems
Tissue-specific considerations:
Focus analyses on tissues with high FAM136A expression, particularly sensory epithelium
Design developmental time-course studies to identify critical periods of FAM136A function
Consider examining both larval (pre-metamorphic) and post-metamorphic stages given the fundamental immune and physiological changes that occur during metamorphosis
Methodological recommendations:
Use conditional knockout or inducible knockdown systems to bypass potential early developmental requirements
Incorporate metabolomic analysis to identify biochemical pathways affected by FAM136A deficiency
Employ live imaging of developing Xenopus embryos to capture dynamic aspects of mitochondrial behavior
Low expression of recombinant Xenopus tropicalis FAM136A can be addressed through several optimization strategies:
Expression system optimization:
Compare yeast, mammalian, and E. coli expression systems to identify optimal host
For yeast systems, test different promoter strengths and induction conditions
Consider codon optimization of the FAM136A sequence for the expression host
Test expression of different FAM136A isoforms, as some may express more efficiently than others
Fusion tag strategies:
Compare N-terminal vs. C-terminal His tags for impact on expression and folding
Test solubility-enhancing fusion partners (SUMO, MBP, GST) while ensuring tag removal does not compromise function
Evaluate the impact of tag position on mitochondrial targeting sequences, which may affect folding
Culture condition optimization:
Adjust temperature, media composition, and induction timing to maximize expression
Implement fed-batch culture strategies to achieve higher cell densities and protein yields
For difficult constructs, consider low-temperature expression to improve folding kinetics
RNA and protein stability enhancements:
Identify and modify RNA secondary structures that may impede translation
Incorporate stabilizing mutations identified through directed evolution or computational design
Implement protease inhibition strategies during expression and purification
When multiple approaches fail to yield sufficient protein, consider whether the native FAM136A contains features inherently challenging for recombinant expression, such as regions prone to aggregation or post-translational modifications critical for stability.
Addressing inconsistency in FAM136A functional studies requires systematic evaluation of experimental variables:
Biological source variability:
Different strains of Xenopus tropicalis show genetic diversity that may influence experimental outcomes
The genetic distance between Nigerian and Ivory Coast strains should be considered when comparing results across studies
Developmental stage significantly impacts gene expression and response patterns, particularly during metamorphosis
Technical approach standardization:
Standardize gene editing protocols, including guide RNA design and delivery methods
Implement quantitative assessment of editing efficiency in each experiment
Ensure consistent animal husbandry conditions, as temperature and other environmental factors influence Xenopus physiology
Isoform-specific considerations:
Data integration approaches:
Implement multiple complementary techniques to assess each aspect of FAM136A function
Develop clear phenotypic scoring systems with blinded assessment to reduce observer bias
Use statistical approaches appropriate for the inherent variability in biological systems
Researchers should maintain detailed records of all experimental conditions, including animal source, developmental timing, reagent sources, and environmental parameters to facilitate robust cross-study comparisons and reproducibility.